Anti-Aging · Reference
TITAN Blend Dosage: The Four Peptides in Units, mL and mg
This page explains the TITAN dosage Pepti prescribes, what the units on the syringe mean, how much of each peptide is in a dose, a dosage chart for the TITAN vial, how a TITAN dose compares with the products next to it, when it is taken, what can change your directions, and the side effects to know about. It covers how Pepti prescribes TITAN, not online protocols. Nothing here is a reason to change your own dose.
At Pepti, the TITAN blend is prescribed as 0.25 mL, which is 25 units on a U-100 insulin syringe, injected under the skin Monday through Friday nights at bedtime. The 5 mL vial holds 10 mg tesamorelin, 6 mg CJC-1295, 12 mg ipamorelin and 10 mg BPC-157, so every 0.25 mL dose delivers 0.5 mg tesamorelin, 0.3 mg CJC-1295, 0.6 mg ipamorelin and 0.5 mg BPC-157, and the vial holds 20 doses, about four weeks. Your physician sets your directions after reviewing your intake, and your exact dose and units are printed on the vial. The four peptides are in fixed proportion, so every draw delivers the same split.
This page explains the TITAN dosage Pepti prescribes, what the units on the syringe mean, how much of each peptide is in a dose, a dosage chart for the TITAN vial, how a TITAN dose compares with the products next to it, when it is taken, what can change your directions, and the side effects to know about. It covers how Pepti prescribes TITAN, not online protocols. Nothing here is a reason to change your own dose.
TITAN Blend Dosage
The short answer
| Product | Vial | Typical directions | Per dose | Doses per vial | Price |
|---|---|---|---|---|---|
| TITAN Blend | 5 mL: tesamorelin 2 mg/mL, CJC-1295 1.2 mg/mL, ipamorelin 2.4 mg/mL, BPC-157 2 mg/mL | Inject 0.25 mL (25 units) subcutaneously Monday through Friday nights at bedtime | 0.5 mg tesamorelin, 0.3 mg CJC-1295, 0.6 mg ipamorelin, 0.5 mg BPC-157 | 20 | $289/mo |
The price is all-in, covering medication, physician review, refill management and shipping, with no separate membership fee. Pepti is cash-pay and does not bill insurance. These are the typical printed directions; your own directions are the ones on your vial.
TITAN Blend Dosage
What TITAN is, briefly
TITAN is four independently studied peptides dissolved together in one sterile multi-dose vial. Three of them prompt the pituitary to release your own growth hormone: tesamorelin and CJC-1295 are analogues of growth-hormone-releasing hormone (GHRH) and act on the GHRH receptor, and ipamorelin acts on the ghrelin receptor, GHS-R1a, a second signal that converges on the same pulse. The fourth, BPC-157, has nothing to do with the growth hormone axis. It is a 15-amino-acid fragment of a protein found in human gastric juice, studied in animals for tendon, ligament and gut-lining repair. The name TITAN is a brand name for the combination; it does not appear in any journal, and the combination has never been studied as a combination. The full reference is what is TITAN.
TITAN Blend Dosage
TITAN dosage in units, mL and mg
Pepti's directions are written in two forms, millilitres and units, because prescriptions are written in millilitres and insulin syringes are marked in units. On a U-100 insulin syringe, 1 unit is 0.01 mL, so 100 units is 1 mL and 25 units is 0.25 mL. A unit is a volume mark on the barrel, not a measure of how strong the medication is.
A four-peptide vial has four concentrations on its label, and each gives its own milligram figure from the same draw:
| Component | Concentration | Per vial | Per 0.25 mL dose |
|---|---|---|---|
| Tesamorelin | 2 mg/mL | 10 mg | 0.5 mg |
| CJC-1295 | 1.2 mg/mL | 6 mg | 0.3 mg |
| Ipamorelin | 2.4 mg/mL | 12 mg | 0.6 mg |
| BPC-157 | 2 mg/mL | 10 mg | 0.5 mg |
| Total | 38 mg | 1.9 mg |
That arithmetic is a way to read a label, not a way to set a dose. A vial labelled 38 mg in total is not a 38 mg dose: it is twenty doses of 1.9 mg combined. If your label and your syringe seem to disagree, do not dose; message your care team. How long does a peptide vial last explains every number on a vial label.
Fixed proportions
The four peptides are in a ratio fixed by the pharmacy's formulation. Every dose delivers the same split, and there is no way to take more of one and less of another from the same vial. Ipamorelin is 12 of the 38 mg, tesamorelin and BPC-157 10 each, and CJC-1295 6. By mass, roughly three quarters of TITAN is growth hormone secretagogue and one quarter is the repair peptide. If a different balance is wanted, the components are prescribed separately.
TITAN Blend Dosage
TITAN dosage chart: units to mL to mg
The chart below is the conversion for the TITAN vial, drawn with a U-100 insulin syringe. It is math only. It is not a menu of doses, and the only line that applies to you is the one that matches the number printed on your vial.
| Syringe mark (U-100) | Volume | Tesamorelin | CJC-1295 | Ipamorelin | BPC-157 |
|---|---|---|---|---|---|
| 5 units | 0.05 mL | 0.1 mg | 0.06 mg | 0.12 mg | 0.1 mg |
| 10 units | 0.1 mL | 0.2 mg | 0.12 mg | 0.24 mg | 0.2 mg |
| 15 units | 0.15 mL | 0.3 mg | 0.18 mg | 0.36 mg | 0.3 mg |
| 20 units | 0.2 mL | 0.4 mg | 0.24 mg | 0.48 mg | 0.4 mg |
| 25 units (Pepti's typical directions) | 0.25 mL | 0.5 mg | 0.3 mg | 0.6 mg | 0.5 mg |
| 50 units | 0.5 mL | 1 mg | 0.6 mg | 1.2 mg | 1 mg |
| 100 units | 1 mL | 2 mg | 1.2 mg | 2.4 mg | 2 mg |
The rule behind every row: units divided by 100 gives millilitres; multiply millilitres by 2 for tesamorelin, 1.2 for CJC-1295, 2.4 for ipamorelin and 2 for BPC-157. Those multipliers only hold for this vial. A chart written for a different blend or concentration gives different milligram figures for the same units, which is the main reason not to dose from a chart, including this one.
TITAN Blend Dosage
TITAN compared with the products next to it
People often compare a TITAN dose with ASCEND, with CJC-1295 / Ipamorelin, or with the single peptides. Here is what each typical printed direction delivers:
| TITAN | ASCEND | CJC-1295 / Ipamorelin | Tesamorelin | BPC-157 | |
|---|---|---|---|---|---|
| What is in the vial | 10 mg tesamorelin, 6 mg CJC-1295, 12 mg ipamorelin, 10 mg BPC-157 | 6 mg CJC-1295, 12 mg ipamorelin, 10 mg tesamorelin, 1 mg IGF-1 LR3 | 6 mg CJC-1295, 12 mg ipamorelin | 10 mg tesamorelin | 5 mg BPC-157 |
| Typical directions | 0.25 mL, weeknights at bedtime | 0.25 mL, weeknights at bedtime | 0.25 mL, once daily Monday through Friday on an empty stomach | 0.25 mL, weeknights at bedtime | 0.18 mL (18 units), once daily |
| Per dose | 0.5 mg tesamorelin, 0.3 mg CJC-1295, 0.6 mg ipamorelin, 0.5 mg BPC-157 | 0.3 mg CJC-1295, 0.6 mg ipamorelin, 0.5 mg tesamorelin, 0.05 mg IGF-1 LR3 | 0.3 mg CJC-1295, 0.6 mg ipamorelin | 0.5 mg tesamorelin | 0.18 mg BPC-157 |
| Price | $289/mo | $289/mo | $239/mo | $249/mo | $209/mo |
What the numbers show
TITAN delivers exactly the same CJC-1295 and ipamorelin per dose as the two-peptide CJC-1295 / Ipamorelin vial, and the same tesamorelin per dose as tesamorelin on its own. Nothing is diluted by being in a blend. That is also why TITAN is not taken alongside any of those products: it would double a component. ASCEND shares the three secretagogues at the same amounts and swaps BPC-157 for IGF-1 LR3, which brings low blood sugar and growth-signalling cautions TITAN does not carry. The BPC-157 in a TITAN dose, 0.5 mg on weeknights, is a larger amount per injection than the single BPC-157 vial's 0.18 mg, given on a different schedule. PHYSIQ vs SHRED vs TITAN compares the neighbouring blends, and the ASCEND arithmetic is in ASCEND blend dosage.
TITAN Blend Dosage
How long a TITAN vial lasts
| Step | Value |
|---|---|
| Dose | 25 units, 0.25 mL |
| Doses per week | 5 (Monday through Friday) |
| Doses per vial | 20 (5 mL divided by 0.25 mL) |
| Used over the vial | 10 mg tesamorelin, 6 mg CJC-1295, 12 mg ipamorelin, 10 mg BPC-157, the whole vial |
| Time per vial | 20 doses divided by 5 per week = 4 weeks |
Four weeks is why refills run every 28 days, one vial per fill. Vials are multi-dose solutions shipped ready to use, refrigerated with ice packs, with sterile syringes and alcohol prep pads. Nothing is mixed at home. Keep the vial in the fridge and follow the beyond-use date printed on the label, which runs from first puncture; a four-peptide vial is not something to keep past it. How to store peptides covers storage.
If a vial runs short before the refill, message your care team rather than adjusting anything yourself. If you miss a weeknight dose, follow your directions and do not take two doses to make up for one.
TITAN Blend Dosage
When TITAN is taken
At bedtime, Monday through Friday
The body's largest growth hormone pulse occurs in the first hours of slow-wave sleep, and the three secretagogues in TITAN are dosed to reinforce it. Prescribers generally direct that the dose be taken away from food, because a rise in blood glucose and insulin blunts growth hormone release. Your directions will say. Weekends off are part of the schedule, not missed doses, and the weekday pattern is a prescriber convention rather than something derived from a trial.
BPC-157 has no timing requirement of its own. It rides along at bedtime because it shares the vial with the secretagogues.
Under the skin
Subcutaneous means into the fat layer, not the muscle. Abdomen and thigh are the usual sites, rotated so the same spot is not used repeatedly. Technique is in how to inject peptides safely.
| Directions say | What it means in practice |
|---|---|
| 0.25 mL (25 units) | Draw to the 25 mark on a U-100 insulin syringe |
| Subcutaneously | Into the fat layer, abdomen or thigh, rotating sites |
| Monday through Friday | Five doses a week, weekends off |
| Nights at bedtime | Shortly before sleep |
| 20 doses per vial | About four weeks, then the next refill |
TITAN Blend Dosage
Why the research cannot give you a TITAN dose
TITAN has never been studied as a blend, in people or in animals, so there is no trial dose for it. The evidence is per component, and it is uneven:
| Component | Dosing in the live research | How it compares with a TITAN dose |
|---|---|---|
| Tesamorelin | 1 or 2 mg once daily in every human trial, including 2 mg daily for 26 weeks (New England Journal of Medicine, 2007) | TITAN delivers 0.5 mg five nights a week |
| CJC-1295 | Single injections of the DAC form in healthy adults (Journal of Clinical Endocrinology and Metabolism, 2006) | TITAN contains the form without DAC, dosed nightly |
| Ipamorelin | Intravenous dosing in volunteers (Pharmaceutical Research, 1999) and after bowel surgery (2014) | TITAN is subcutaneous |
| BPC-157 | Animal and cell studies; no human study of a subcutaneous BPC-157 product has been published | No human subcutaneous dose exists |
None of these used the weeknight schedule or the amounts in this vial, and none combined the peptides. The directions on the vial are a prescribing standard set to deliver one vial in four weeks. The evidence for each component is in tesamorelin dosage, ipamorelin dosage, what is CJC-1295 / Ipamorelin and BPC-157 dosage. What research has looked at, component by component, is in TITAN blend benefits.
TITAN Blend Dosage
What changes the directions
Your physician sets your directions after reviewing your intake. Things that can lead to different directions, or a different product, include:
| What can change | How it shows up |
|---|---|
| Whether TITAN is the right formula | Visceral fat alone may point to tesamorelin; sleep and recovery without the repair peptide to CJC-1295 / Ipamorelin; a tendon or gut problem alone to BPC-157 |
| Your blood sugar | Growth hormone reduces insulin sensitivity, so diabetes or impaired glucose tolerance changes the conversation |
| Cancer history | Growth signalling and BPC-157's described angiogenesis mean a personal history of cancer is raised at intake |
| Blood thinners | BPC-157's described mechanisms are vascular, so anticoagulant or antiplatelet therapy goes on the intake |
| Your other medications | Growth hormone can alter how some drugs are metabolised, so the intake asks for everything you take |
| How you respond | Puffiness, joint aches or hand tingling go to your physician, who may revise your directions |
When directions change, the new numbers are printed on the new label. Never carry a number over from a previous fill. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
TITAN Blend Dosage
Side effects, in summary
| What is reported | What it means | What to do |
|---|---|---|
| Injection-site redness, itching or a small lump | The most common report | Rotate sites |
| A brief flush, headache, hunger after the dose | Reported with the secretagogues | Report it if it persists |
| Puffiness, joint aches, hand tingling | Classic growth hormone effects; usually more than the person needs | Message your care team; do not change the dose yourself |
| Thirst or frequent urination | Possible rise in blood sugar from growth hormone | Message your care team |
| Unexplained bleeding or bruising away from the injection site | A reason to stop and call, given BPC-157's animal clotting signal | Contact your care team the same day |
| Facial or throat swelling, widespread hives, breathing difficulty | Rare hypersensitivity | Emergency care first (call 911), then tell your physician |
Who should not take TITAN, or should discuss it first: anyone with a personal history of cancer, diabetes or impaired glucose tolerance, anyone on a blood thinner, anyone pregnant or breastfeeding, and tested athletes, because GHRH analogues, growth hormone secretagogues and BPC-157 are prohibited in sport. The full list is in TITAN blend side effects.
TITAN is a compounded prescription; compounded medications are not FDA approved. An approved tesamorelin product exists for one specific indication, at a different dose; TITAN itself is not approved for anything.
TITAN Blend Dosage
Where to get TITAN prescribed
TITAN cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested, so the per-dose figures above would not hold. The prescription route:
- Complete a free online intake covering your history, medications, blood sugar, cancer history and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and dose changes.
TITAN is supplied as a vial and syringe only. The assessment confirms whether Pepti prescribes in your state.
References
What this is based on.
References
- Falutz J, Allas S, Blot K et al.. Metabolic effects of a growth hormone-releasing factor in patients with HIV · N Engl J Med (2007) · PMID 18057338
- Teichman SL, Neale A, Lawrence B et al.. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults · J Clin Endocrinol Metab (2006) · PMID 16352683
- Chang CH, Tsai WC, Lin MS et al.. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration · J Appl Physiol (1985) (2011) · PMID 21030672
- Sikiric P, Rucman R, Turkovic B et al.. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing · Curr Pharm Des (2018) · PMID 29879879
- Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? · Endocr Rev (2012) · PMID 22433122
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
TITAN Blend Dosage, answered.
At Pepti, 0.25 mL, which is 25 units on a U-100 insulin syringe, injected subcutaneously Monday through Friday nights at bedtime. Your physician sets your directions after reviewing your intake, and your exact dose is printed on the vial.
At 0.25 mL: 0.5 mg tesamorelin, 0.3 mg CJC-1295, 0.6 mg ipamorelin and 0.5 mg BPC-157, 1.9 mg combined. The split is fixed by the formulation.
The number printed on your vial. Pepti's typical directions are 25 units, which is 0.25 mL on a U-100 insulin syringe.
Twenty. A 5 mL vial divided by 0.25 mL per dose is 20 doses, about four weeks at five nights a week.
The body's largest growth hormone pulse occurs during slow-wave sleep in the first hours of the night, and the three secretagogues are dosed to reinforce it.
Prescribers generally direct that it be taken away from food, because a rise in blood sugar blunts growth hormone release. Follow the food guidance in your own directions, and ask before the first dose if it is unclear.
The CJC-1295 and ipamorelin per dose are identical. TITAN adds 0.5 mg tesamorelin and 0.5 mg BPC-157 to the same draw.
Raise it with your physician first. TITAN already contains each of them, so taking either alongside it doubles that component.
The tesamorelin, CJC-1295 and ipamorelin per dose are identical. TITAN's fourth component is 0.5 mg BPC-157; ASCEND's is 50 mcg IGF-1 LR3.
No. Take the dose printed on your vial, on the schedule printed on your vial. Puffiness and joint aches signal more growth hormone than a person needs. If you have questions about your dose, message your care team.
No. Pepti vials are multi-dose solutions shipped ready to use, with sterile syringes and alcohol prep pads.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.